(redirected from Gynecologic Oncology Group)
Also found in: Wikipedia.
GOGGood Old Games (computer game distribution service)
GOGGynecologic Oncology Group
GOGGuardians of the Galaxy
GOGGrace of God
GOGGrumpy Old Git
GOGGovernment of Gujarat (India)
GOGGovernment of Gibraltar
GOGGift Of God
GOGGirl on Girl
GOGGrease, Oil, Gas
GOGGreat Outdoor Games (Entertainment and Sports Programming Network)
GOGGovernment of Grenada
GOGGulf of Guinea
GOGGuild of Greeters
GOGGreat Artesian Oil & Gas (North Sydney, NSW, Australia)
GOGGods of Gaming (gaming clan)
GOGGuns of Glory (gaming clan)
GOGGood Old Giggle
GOGGlobe of Geek
GOGGathering of Guilds (gaming)
References in periodicals archive ?
A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a gynecologic oncology group study.
Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey.
Interestingly, a study by the Gynecologic Oncology Group found that women who presented with large volume disease and were optimally cytoreduced to less than 1 centimeter residual tumor had inferior survival compared to women who initially presented with disease of one centimeter or less, which raises the possibility of biologic factors related to disease bulk being as important as the degree of achievable surgical cytoreduction [64].
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Armstrong of Johns Hopkins Kimmel Cancer Center in Baltimore and her coinvestigators in the Gynecologic Oncology Group (N.
The data were drawn from four randomized controlled treatment trials performed by the Gynecologic Oncology Group of Roswell Park Cancer Institute, Buffalo, N.
Etiologic heterogeneity in endometrial cancer: evidence from +a Gynecologic Oncology Group trial.
The SOLO 1 study is being conducted in collaboration with the Gynecologic Oncology Group and the SOLO 2 study with the European Network of Gynaecological Oncological Trial Groups.
It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the National Institutes of Health's Pelvic Floor Disorders Network.
In conjunction, the Gynecologic Oncology Group (GOG), a division of the National Cancer Institute, is sponsoring a US study in recurrent/refractory cervical cancer.